Mary van den Berg-Wolf

TitleAssoc Professor
InstitutionThomas Jefferson University
DepartmentInternal Medicine-Primary Care
Address225 City Avenue
Bala Cynwyd PA 19004
Phone610-664-0521
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. van den Berg-Wolf M. Government Actions to Curb the Opioid Epidemic. JAMA. 2018 04 17; 319(15):1619. PMID: 29677293.
      Citations:    
    2. Nadhan KS, Warner CG, van den Berg-Wolf M, Civan JM, Ballal S, Chung CL. Palmoplantar keratoderma as a presenting sign of primary biliary cirrhosis. JAAD Case Rep. 2018 Jan; 4(1):41-43. PMID: 29270458.
      Citations:    
    3. van den Berg-Wolf M, Burgoon T. Acupuncture and Cutaneous Medicine: Is It Effective? Med Acupunct. 2017 Oct 01; 29(5):269-275. PMID: 29067137.
      Citations:    
    4. Simoncini GM, Megill M, van den Berg-Wolf M. Reducing False-Positive HIV Diagnosis in Niger: A Women's Issue. J Int Assoc Provid AIDS Care. 2016 Jan-Feb; 15(1):15-8. PMID: 25979258.
      Citations:    
    5. Simoncini GM, Khan EK, van den Berg-Wolf M. Electronic cigarettes: a perspective for the primary care physician. South Med J. 2014 Oct; 107(10):630-2. PMID: 25279866.
      Citations:    
    6. van den Berg-Wolf M. Acupuncture is more than placebo treatment. Am J Med. 2014 Oct; 127(10):e23. PMID: 25311073.
      Citations:    
    7. Phongtankuel V, Schrank G, Campbell EN, Holtzman C, Gaughan JP, van den Berg-Wolf M. Elevated testosterone levels in HIV-infected men: case report and a retrospective chart review. J Int Assoc Provid AIDS Care. 2013 Sep-Oct; 12(5):315-8. PMID: 23735854.
      Citations:    
    8. Tedaldi EM, van den Berg-Wolf M, Richardson J, Patel P, Durham M, Hammer J, Henry K, Metzler S, Ă–nen N, Conley L, Wood K, Brooks JT, Buchacz K. Sadness in the SUN: using computerized screening to analyze correlates of depression and adherence in HIV-infected adults in the United States. AIDS Patient Care STDS. 2012 Dec; 26(12):718-29. PMID: 23199190.
      Citations:    
    9. Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TR. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. Am J Public Health. 2010 Oct; 100(10):1896-903. PMID: 20724677.
      Citations:    
    10. van den Berg-Wolf M, Tedaldi EM. Therapeutic strategies for chronic hepatitis B virus infection in 2008-optimum dosing lamivudine challenged for HIV-1 infected patients. Am J Med. 2009 Aug; 122(8):e11. PMID: 19635261.
      Citations:    
    11. van den Berg-Wolf M, Hullsiek KH, Peng G, Kozal MJ, Novak RM, Chen L, Crane LR, Macarthur RD. Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons. HIV Clin Trials. 2008 Sep-Oct; 9(5):324-36. PMID: 18977721.
      Citations:    
    12. van den Berg-Wolf M, Klibanov OM, Gaughan JP, Tedaldi EM. Ezetimibe combined with low-dose statin effectively lowers LDL in protease inhibitor treated patients. AIDS Patient Care STDS. 2008 Jun; 22(6):483-8. PMID: 18462073.
      Citations:    
    13. Tedaldi EM, Absalon J, Thomas AJ, Shlay JC, van den Berg-Wolf M. Ethnicity, race, and gender. Differences in serious adverse events among participants in an antiretroviral initiation trial: results of CPCRA 058 (FIRST Study). J Acquir Immune Defic Syndr. 2008 Apr 1; 47(4):441-8. PMID: 18176329.
      Citations:    
    14. MacArthur RD, Novak RM, Peng G, Chen L, Xiang Y, Hullsiek KH, Kozal MJ, van den Berg-Wolf M, Henely C, Schmetter B, Dehlinger M. A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial. Lancet. 2006 Dec 16; 368(9553):2125-35. PMID: 17174704.
      Citations:    
    15. Novak RM, Chen L, MacArthur RD, Baxter JD, Huppler Hullsiek K, Peng G, Xiang Y, Henely C, Schmetter B, Uy J, van den Berg-Wolf M, Kozal M. Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy. Clin Infect Dis. 2005 Feb 1; 40(3):468-74. PMID: 15668873.
      Citations:    
    van den Berg-Wolf's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (80)
    Explore
    _
    Co-Authors (1)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _